- Home
- MOGU vs IGC Comparison
MOGU vs IGC Comparison
Compare MOGU & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- IGC
- Stock Information
- Founded
- MOGU 2011
- IGC 2005
- Country
- MOGU China
- IGC United States
- Employees
- MOGU N/A
- IGC N/A
- Industry
- MOGU Business Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- IGC Health Care
- Exchange
- MOGU Nasdaq
- IGC Nasdaq
- Market Cap
- MOGU 17.8M
- IGC 20.2M
- IPO Year
- MOGU 2018
- IGC N/A
- Fundamental
- Price
- MOGU $2.18
- IGC $0.31
- Analyst Decision
- MOGU
- IGC Strong Buy
- Analyst Count
- MOGU 0
- IGC 2
- Target Price
- MOGU N/A
- IGC $3.88
- AVG Volume (30 Days)
- MOGU 3.5K
- IGC 219.7K
- Earning Date
- MOGU 07-08-2025
- IGC 08-07-2025
- Dividend Yield
- MOGU N/A
- IGC N/A
- EPS Growth
- MOGU N/A
- IGC N/A
- EPS
- MOGU N/A
- IGC N/A
- Revenue
- MOGU $19,801,126.00
- IGC $1,236,000.00
- Revenue This Year
- MOGU N/A
- IGC N/A
- Revenue Next Year
- MOGU N/A
- IGC $16.45
- P/E Ratio
- MOGU N/A
- IGC N/A
- Revenue Growth
- MOGU N/A
- IGC 1.65
- 52 Week Low
- MOGU $1.81
- IGC $0.25
- 52 Week High
- MOGU $3.14
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- MOGU 52.62
- IGC 52.79
- Support Level
- MOGU $2.05
- IGC $0.30
- Resistance Level
- MOGU $2.17
- IGC $0.32
- Average True Range (ATR)
- MOGU 0.05
- IGC 0.01
- MACD
- MOGU 0.01
- IGC 0.00
- Stochastic Oscillator
- MOGU 92.86
- IGC 33.33
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.